• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma: a case report and literature review].

作者信息

Huang A J, Ni X, Fu W J, Zhang Y, Tang G S, Wang J M

机构信息

Department of Hematology, Institute of Hematology, The First Affiliated Hospital of Naval Medical University, Changhai Hospital, Shanghai 200433, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):338-342. doi: 10.3760/cma.j.issn.0253-2727.2021.04.012.

DOI:10.3760/cma.j.issn.0253-2727.2021.04.012
PMID:33979980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8120127/
Abstract
摘要

相似文献

1
[Rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma: a case report and literature review].[利妥昔单抗致脾边缘区淋巴瘤患者急性血小板减少症：1例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):338-342. doi: 10.3760/cma.j.issn.0253-2727.2021.04.012.
2
Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.一名脾边缘区淋巴瘤患者在发生严重的利妥昔单抗诱导的急性血小板减少症后成功再次使用利妥昔单抗。
J Oncol Pharm Pract. 2020 Jul;26(5):1248-1253. doi: 10.1177/1078155219890023. Epub 2019 Nov 25.
3
A Case of Rituximab-Induced Acute Thrombocytopenia in a Patient with Splenic Marginal Zone Lymphoma and Chronic Hepatitis C Virus Infection.1例利妥昔单抗诱导的脾边缘区淋巴瘤合并慢性丙型肝炎病毒感染患者急性血小板减少症
Am J Case Rep. 2019 Sep 21;20:1394-1397. doi: 10.12659/AJCR.917644.
4
Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma.利妥昔单抗致脾脏边缘区淋巴瘤患者严重急性血小板减少症
J Oncol Pharm Pract. 2023 Jun;29(4):1011-1014. doi: 10.1177/10781552221142870. Epub 2022 Dec 1.
5
[Rituximab-induced acute thrombocytopenia in a patient with chronic lymphocytic leukemia].[利妥昔单抗诱导的慢性淋巴细胞白血病患者急性血小板减少症]
Rev Med Interne. 2017 May;38(5):344-346. doi: 10.1016/j.revmed.2016.08.008. Epub 2016 Sep 14.
6
Rituximab-induced acute thrombocytopenia in patients with splenomegaly B Cell lymphoma: an underdiagnosed but severe complication.利妥昔单抗致脾肿大 B 细胞淋巴瘤患者的急性血小板减少症：一种被低估但严重的并发症。
Cancer Biol Ther. 2020 Nov 1;21(11):1060-1066. doi: 10.1080/15384047.2020.1832017. Epub 2020 Oct 29.
7
A new taxonomy for splenic marginal zone lymphoma.
Blood. 2022 Feb 3;139(5):644-645. doi: 10.1182/blood.2021014198.
8
Splenic marginal zone lymphoma: a case report and literature review.脾边缘区淋巴瘤：一例报告及文献复习
World J Surg Oncol. 2020 Oct 1;18(1):259. doi: 10.1186/s12957-020-02030-3.
9
A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade.脾边缘区淋巴瘤对一线检查点阻断的深度分子反应。
Haematologica. 2021 Feb 1;106(2):651-654. doi: 10.3324/haematol.2020.258426.
10
Pseudo-faggot cells in splenic marginal zone lymphoma.
Br J Haematol. 2023 Apr;201(1):7. doi: 10.1111/bjh.18621. Epub 2023 Jan 6.

引用本文的文献

1
Obinutuzumab-induced acute thrombocytopenia: a case report and literature review.奥滨尤妥珠单抗诱导的急性血小板减少症：一例病例报告及文献综述
Front Oncol. 2024 Dec 17;14:1509567. doi: 10.3389/fonc.2024.1509567. eCollection 2024.

本文引用的文献

1
Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.一名脾边缘区淋巴瘤患者在发生严重的利妥昔单抗诱导的急性血小板减少症后成功再次使用利妥昔单抗。
J Oncol Pharm Pract. 2020 Jul;26(5):1248-1253. doi: 10.1177/1078155219890023. Epub 2019 Nov 25.
2
A Case of Rituximab-Induced Acute Thrombocytopenia in a Patient with Splenic Marginal Zone Lymphoma and Chronic Hepatitis C Virus Infection.1例利妥昔单抗诱导的脾边缘区淋巴瘤合并慢性丙型肝炎病毒感染患者急性血小板减少症
Am J Case Rep. 2019 Sep 21;20:1394-1397. doi: 10.12659/AJCR.917644.
3
Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma.一名高危套细胞淋巴瘤患者出现自发性脾破裂和利妥昔单抗诱导的急性血小板减少症。
Case Rep Hematol. 2019 Apr 7;2019:2429098. doi: 10.1155/2019/2429098. eCollection 2019.
4
Disseminated Intravascular Coagulation-like Reaction after Rituximab Infusion in a Patient with Nephrotic Syndrome.一名肾病综合征患者在输注利妥昔单抗后出现弥散性血管内凝血样反应。
Intern Med. 2019 Jul 15;58(14):2057-2061. doi: 10.2169/internalmedicine.2236-18. Epub 2019 Mar 28.
5
Infusion-related reactions to rituximab: frequency, mechanisms and predictors.利妥昔单抗相关输注反应：频率、机制和预测因素。
Expert Rev Clin Immunol. 2019 Apr;15(4):383-389. doi: 10.1080/1744666X.2019.1562905. Epub 2019 Jan 11.
6
Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.利妥昔单抗诱发的肉芽肿性多血管炎伴发急性血小板减少症
Intern Med. 2018 Aug 1;57(15):2247-2250. doi: 10.2169/internalmedicine.0335-17. Epub 2018 Mar 9.
7
Rituximab-induced Acute Thrombocytopenia in a Patient with Follicular Lymphoma: A Case Report and Review of the Literature.利妥昔单抗致滤泡性淋巴瘤患者急性血小板减少症：一例报告并文献复习
Intern Med. 2018 Apr 15;57(8):1151-1154. doi: 10.2169/internalmedicine.9628-17. Epub 2017 Dec 21.
8
Disseminated intravascular coagulation-like reaction following rituximab infusion.利妥昔单抗输注后出现弥散性血管内凝血样反应。
BMJ Case Rep. 2017 Feb 8;2017:bcr2016218443. doi: 10.1136/bcr-2016-218443.
9
Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma.利妥昔单抗诱导的高肿瘤负荷滤泡性淋巴瘤患者急性血小板减少症
Intern Med. 2016;55(15):2061-4. doi: 10.2169/internalmedicine.55.6140. Epub 2016 Aug 1.
10
The platelet Fc receptor, FcγRIIa.血小板 Fc 受体，FcγRIIa。
Immunol Rev. 2015 Nov;268(1):241-52. doi: 10.1111/imr.12370.